Nalinee Sangrujee

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Global surveillance and the value of information: the case of the global polio laboratory network
    Esther de Gourville
    World Health Organization, Department of Immunization, Vaccines and Biologicals, Geneva, Switzerland
    Risk Anal 26:1557-69. 2006
  2. ncbi Policy decision options during the first 5 years following certification of polio eradication
    Nalinee Sangrujee
    Centers for Disease Control and Prevention, National Immunization Program, Global Immunization Division, Polio Eradication Branch, Atlanta, Georgia, USA
    MedGenMed 5:35. 2003
  3. ncbi Cost analysis of post-polio certification immunization policies
    Nalinee Sangrujee
    Centers for Disease Control and Prevention, National Immunization Program, 1600 Clifton Rd, MS E05, Atlanta, GA 30333, USA
    Bull World Health Organ 82:9-15. 2004
  4. ncbi Cost-effectiveness of three different vaccination strategies against measles in Zambian children
    Gustavo H Dayan
    Centers for Disease Control and Prevention, National Immunization Program, 1600 Clifton Road, Mailstop E 61, Atlanta, GA 30333, USA
    Vaccine 22:475-84. 2004
  5. ncbi Factors affecting U.S. manufacturers' decisions to produce vaccines
    Margaret S Coleman
    U S Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Health Aff (Millwood) 24:635-42. 2005
  6. ncbi Measles supplemental immunization activities improve measles vaccine coverage and equity: Evidence from Kenya, 2002
    Maya Vijayaraghavan
    Centers for Disease Control and Prevention, 1600 Clifton Road, Mail Stop E 05, Atlanta GA 30333, United States
    Health Policy 83:27-36. 2007
  7. ncbi The costs of future polio risk management policies
    Radboud J Duintjer Tebbens
    Kids Risk Project, Harvard School of Public Health, 677 Huntington Ave, 3rd Floor, Boston, MA 02115, USA
    Risk Anal 26:1507-31. 2006
  8. ncbi Development and consideration of global policies for managing the future risks of poliovirus outbreaks: insights and lessons learned through modeling
    Kimberly M Thompson
    Kids Risk Project, Harvard School of Public Health, 677 Huntington Ave, 3rd Floor, Boston, MA 02115, USA
    Risk Anal 26:1571-80. 2006

Collaborators

Detail Information

Publications8

  1. ncbi Global surveillance and the value of information: the case of the global polio laboratory network
    Esther de Gourville
    World Health Organization, Department of Immunization, Vaccines and Biologicals, Geneva, Switzerland
    Risk Anal 26:1557-69. 2006
    ..We also provided important insights about how the value of information may change after successful eradication of wild polioviruses...
  2. ncbi Policy decision options during the first 5 years following certification of polio eradication
    Nalinee Sangrujee
    Centers for Disease Control and Prevention, National Immunization Program, Global Immunization Division, Polio Eradication Branch, Atlanta, Georgia, USA
    MedGenMed 5:35. 2003
    ..While the management of polio risk in the postcertification period presents important challenges, this comprehensive approach helps simplify the process by focusing on critical decisions...
  3. ncbi Cost analysis of post-polio certification immunization policies
    Nalinee Sangrujee
    Centers for Disease Control and Prevention, National Immunization Program, 1600 Clifton Rd, MS E05, Atlanta, GA 30333, USA
    Bull World Health Organ 82:9-15. 2004
    ..An analysis was conducted to estimate the costs of different potential post-polio certification immunization policies currently under consideration, with the objective of providing this information to policy-makers...
  4. ncbi Cost-effectiveness of three different vaccination strategies against measles in Zambian children
    Gustavo H Dayan
    Centers for Disease Control and Prevention, National Immunization Program, 1600 Clifton Road, Mailstop E 61, Atlanta, GA 30333, USA
    Vaccine 22:475-84. 2004
    ..Given the parameters established for this analysis, such a program would be cost-saving and the most cost-effective vaccination strategy for Zambia...
  5. ncbi Factors affecting U.S. manufacturers' decisions to produce vaccines
    Margaret S Coleman
    U S Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Health Aff (Millwood) 24:635-42. 2005
    ..All four manufacturers are investing more in research and development because new technologies have advanced their ability to create vaccines not thought possible before...
  6. ncbi Measles supplemental immunization activities improve measles vaccine coverage and equity: Evidence from Kenya, 2002
    Maya Vijayaraghavan
    Centers for Disease Control and Prevention, 1600 Clifton Road, Mail Stop E 05, Atlanta GA 30333, United States
    Health Policy 83:27-36. 2007
    ....
  7. ncbi The costs of future polio risk management policies
    Radboud J Duintjer Tebbens
    Kids Risk Project, Harvard School of Public Health, 677 Huntington Ave, 3rd Floor, Boston, MA 02115, USA
    Risk Anal 26:1507-31. 2006
    ..OPV immunization...
  8. ncbi Development and consideration of global policies for managing the future risks of poliovirus outbreaks: insights and lessons learned through modeling
    Kimberly M Thompson
    Kids Risk Project, Harvard School of Public Health, 677 Huntington Ave, 3rd Floor, Boston, MA 02115, USA
    Risk Anal 26:1571-80. 2006
    ..This analytical journey has provided several key insights and lessons learned that will be useful to future analysts involved in similar complex decision-making processes...